Anti-interleukin-5 therapy and severe asthma
- PMID: 19522047
Anti-interleukin-5 therapy and severe asthma
Comment on
-
Mepolizumab and exacerbations of refractory eosinophilic asthma.N Engl J Med. 2009 Mar 5;360(10):973-84. doi: 10.1056/NEJMoa0808991. N Engl J Med. 2009. PMID: 19264686 Free PMC article. Clinical Trial.
-
Eosinophils in asthma--closing the loop or opening the door?N Engl J Med. 2009 Mar 5;360(10):1026-8. doi: 10.1056/NEJMe0900334. N Engl J Med. 2009. PMID: 19264692 No abstract available.
Similar articles
-
Eosinophils in asthma--closing the loop or opening the door?N Engl J Med. 2009 Mar 5;360(10):1026-8. doi: 10.1056/NEJMe0900334. N Engl J Med. 2009. PMID: 19264692 No abstract available.
-
Anti-interleukin-5 therapy and severe asthma.N Engl J Med. 2009 Jun 11;360(24):2576; author reply 2577. doi: 10.1056/NEJMc090685. N Engl J Med. 2009. PMID: 19516040 No abstract available.
-
Anti-interleukin-5 therapy and severe asthma.N Engl J Med. 2009 Jun 11;360(24):2576-7; author reply 2577. N Engl J Med. 2009. PMID: 19522046 No abstract available.
-
Eosinophils and interleukin-5: the debate continues.Am J Respir Crit Care Med. 2003 Jun 15;167(12):1586-7. doi: 10.1164/rccm.2304001. Am J Respir Crit Care Med. 2003. PMID: 12796050 Review. No abstract available.
-
Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma.Ther Adv Respir Dis. 2015 Aug;9(4):135-45. doi: 10.1177/1753465815581279. Epub 2015 Apr 21. Ther Adv Respir Dis. 2015. PMID: 25900924 Review.
Cited by
-
Biological Modulators in Eosinophilic Diseases.Clin Rev Allergy Immunol. 2016 Apr;50(2):252-72. doi: 10.1007/s12016-014-8444-9. Clin Rev Allergy Immunol. 2016. PMID: 25129490 Review.
-
A current review on animal models of anti-asthmatic drugs screening.Front Pharmacol. 2025 Jan 28;16:1508460. doi: 10.3389/fphar.2025.1508460. eCollection 2025. Front Pharmacol. 2025. PMID: 39981184 Free PMC article. Review.
-
What targeting eosinophils has taught us about their role in diseases.J Allergy Clin Immunol. 2010 Jul;126(1):16-25; quiz 26-7. doi: 10.1016/j.jaci.2010.02.026. J Allergy Clin Immunol. 2010. PMID: 20434203 Free PMC article. Review.
-
Pin1-FADD interactions regulate Fas-mediated apoptosis in activated eosinophils.J Immunol. 2013 May 15;190(10):4937-45. doi: 10.4049/jimmunol.1202646. Epub 2013 Apr 19. J Immunol. 2013. PMID: 23606538 Free PMC article.
-
Transforming Growth Factor-β1 Antagonizes Interleukin-5 Pro-Survival Signaling by Activating Calpain-1 in Primary Human Eosinophils.J Clin Cell Immunol. 2011 Nov 15;Suppl 1:003. doi: 10.4172/2155-9899.S1-003. J Clin Cell Immunol. 2011. PMID: 24244891 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical